Concurrent OCT and FFR-guided PCI in CAD
Recruiting now · Not applicable
Conditions studied: Coronary Artery Disease, Image, Atheroscleroses, Coronary
In brief
The present study is a prospective randomized clinical trial aimed to compare the therapeutic strategy of angiography-guided versus concurrent OCT/FFR-guided intervention in patients with coronary artery disease.
Key facts
- Study ID
- NCT06182683
- Run by
- Korea University Guro Hospital
- People needed
- 700
- Starts
- 2023-11-30
- Expected to finish
- 2029-12-31
- Last updated by the study team
- 2023-12-27
Who can join
Age: 19 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age greater than 19 years old
- Patients undergoing coronary stent implantation for stable angina or acute coronary syndrome
- Patients provided on informed consent
You may not qualify if…
- Individuals with a history of increased bleeding tendencies or hematologic disorders
- Presented with refractory cardiogenic shock
- Individuals with a history of stent thrombosis
- Expected life expectancy of less than 1 year
- Left ventricular ejection fraction (LVEF) ≥ 20%
- Women who are breastfeeding, pregnant, or planning to become pregnant
- Deemed unsuitable for participation by the investigator
- Patients unwilling to participate in the clinical trial
Where it is running
- Korea University Guro Hospital — Seoul, South Korea (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.